January 10, 2025 - 00:56

Credit card defaults among Americans have hit a concerning peak, reaching the highest level seen in 14 years. This alarming trend can be attributed to a combination of soaring credit card debt and persistent high inflation rates. As consumers grapple with rising costs, many are struggling to keep up with their monthly payments.
A borrower is considered to be in default when they fail to make credit card payments for more than 180 days, or roughly six months. This situation not only affects the individual’s credit score but can also lead to significant financial repercussions. As defaults increase, it raises concerns about the overall economic landscape and the potential for a ripple effect that could impact lenders and the economy at large.
Financial experts urge consumers to be proactive in managing their debt and to seek assistance if they find themselves unable to meet their payment obligations. Understanding the implications of defaulting on credit cards is crucial for maintaining financial health in these challenging times.
May 31, 2026 - 03:22
Why a Fund Made a $143 Million Bet on Indivior With Shares Up a Staggering 200%A single investment fund has placed a staggering $143 million wager on Indivior, a pharmaceutical company whose shares have skyrocketed roughly 200% over the past year. The bold move comes as the...
May 30, 2026 - 04:48
Citizens Financial Group Links Rhode Island Training Push To Long Term StoryCitizens Financial Group has announced new community investments in Rhode Island that focus on workforce development and financial education. The company introduced a statewide Banking...
May 29, 2026 - 18:50
Was Trump's investment in a sushi restaurant a mistake? Why some financial experts say Trump’s trades smell fishyA recent investment by former President Donald Trump has sparked confusion and criticism from financial experts, who are questioning whether the move was a costly error. Trump reportedly put money...
May 29, 2026 - 00:56
VERAXA Biotech Secures $27.5M Financing, to Go Public Via SPACSwiss biotech firm VERAXA Biotech AG has secured a significant financial commitment as it prepares to list on the Nasdaq. The company announced it has entered into a securities purchase agreement...